Article Information
- Received May 5, 2010
- Revision received June 29, 2010
- Accepted July 15, 2010
- First published September 8, 2010.
- Version of record published September 8, 2010.
Author Information
- Martin Novak1,*,
- Briac Halbout2,*,
- Eoin C. O'Connor3,*,
- Jan Rodriguez Parkitna1,
- Tian Su1,
- Minqiang Chai1,
- Hans S. Crombag3,
- Ainhoa Bilbao2,
- Rainer Spanagel2,
- David N. Stephens3,
- Günther Schütz1, and
- David Engblom1,4
- 1Molecular Biology of the Cell I, German Cancer Research Center, 69120 Heidelberg, Germany,
- 2Department of Psychopharmacology, Central Institute of Mental Health, J5, 68159 Mannheim, Germany,
- 3School of Psychology, University of Sussex, Brighton, BN1 9QG, United Kingdom, and
- 4Department of Clinical and Experimental Medicine, Linköping University, 58185, Linköping, Sweden
- Correspondence should be addressed to either of the following: David Engblom, Department of Clinical and Experimental Medicine, Linköping University, 58185, Linköping, Sweden, david.engblom{at}liu.se; David N. Stephens, School of Psychology, University of Sussex, Brighton BN1 9QG, UK, E-mail: d.stephens{at}sussex.ac.uk; or Rainer Spanagel, Department of Psychopharmacology, Central Institute of Mental Health, J5, 68159 Mannheim, Germany, E-mail: rainer.spanagel{at}zi-mannheim.de
Author contributions
↵*M.N., B.H., and E.C.O. contributed equally to the work.
Disclosures
- Received May 5, 2010.
- Revision received June 29, 2010.
- Accepted July 15, 2010.
This work was supported by the Deutsche Forschungsgemeinschaft through Collaborative Research Centers SFB 488 and SFB 636, by the Fonds der Chemischen Industrie, the European Union through Grant LSHM-CT-2005-018652 (CRESCENDO), the Bundesministerium für Bildung und Forschung through NGFNplus Grants FZK 01GS08153 and 01GS08142, the Helmholtz Gemeinschaft Deutscher Forschungszentren through Initiative CoReNe and Alliance HelMA, and the Deutsche Krebshilfe through project 108567. D.E. was supported by the Swedish Research Council, the Thuring, Wiberg and Jeansson foundations and the Swedish Society of Medicine. E.C.O. receives a studentship from the Biotechnology and Biological Sciences Research Council and Pfizer Inc. Research in D.N.S.'s laboratory is supported by the United Kingdom Medical Research Council. H.S.C. was supported by a Marie Curie reintegration award. We thank Ali Nasr Esfahani for help with immunohistochemistry, Milen Kirilov and Daniel Habermehl for input on short RNAs, and Witold Konopka for valuable suggestions.
- Correspondence should be addressed to either of the following: David Engblom, Department of Clinical and Experimental Medicine, Linköping University, 58185, Linköping, Sweden, david.engblom{at}liu.se; David N. Stephens, School of Psychology, University of Sussex, Brighton BN1 9QG, UK, E-mail: d.stephens{at}sussex.ac.uk; or Rainer Spanagel, Department of Psychopharmacology, Central Institute of Mental Health, J5, 68159 Mannheim, Germany, E-mail: rainer.spanagel{at}zi-mannheim.de
